Your browser doesn't support javascript.
loading
Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis.
Moein, Anita; Lu, Tong; Jönsson, Siv; Ribbing, Jakob; Kassir, Nastya; Zhang, Wenhui; Sperinde, Gizette; Zhang, Rong; Tang, Meina; Oh, Young S; Bruno, Rene; Zhu, Rui.
Affiliation
  • Moein A; Genentech, Inc., South San Francisco, California, USA.
  • Lu T; Genentech, Inc., South San Francisco, California, USA.
  • Jönsson S; Pharmetheus AB, Uppsala, Sweden.
  • Ribbing J; Pharmetheus AB, Uppsala, Sweden.
  • Kassir N; Genentech, Inc., South San Francisco, California, USA.
  • Zhang W; Genentech, Inc., South San Francisco, California, USA.
  • Sperinde G; Genentech, Inc., South San Francisco, California, USA.
  • Zhang R; Genentech, Inc., South San Francisco, California, USA.
  • Tang M; Genentech, Inc., South San Francisco, California, USA.
  • Oh YS; Genentech, Inc., South San Francisco, California, USA.
  • Bruno R; Genentech/Roche, Marseille, France.
  • Zhu R; Genentech, Inc., South San Francisco, California, USA.
CPT Pharmacometrics Syst Pharmacol ; 11(9): 1244-1255, 2022 09.
Article in En | MEDLINE | ID: mdl-35851998
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative Type of study: Prognostic_studies Limits: Humans Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative Type of study: Prognostic_studies Limits: Humans Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2022 Type: Article Affiliation country: United States